Glenview unloads $317M CVS stake near 52-week high

CVS's chairman sold $317.5M this week. Discretionary. Not a scheduled 10b5-1 sale, which means Larry Robbins picked the timing himself. He unloaded 41.1% of his position at $93.32, just under the 52-week high of $98. The stock's been range-bound all year, flat at 0% YTD, but Robbins took his exit near the top of that range.

Here's the conflict: CVS just announced a $40B acquisition of Signify Health four months ago, positioning itself as a vertically integrated healthcare giant. The chairman reduces his stake by nearly half while the company doubles down on expansion. He's been on the board since 2022. This is his first major exit. The filing shows discretionary. The timing shows something else.

CDW insider buys $499K after 43% drop from highs

Director Leahy just put $499K into CDW at $107, buying it discretionary while the stock sits 43% below its 52-week high. She added 2.4% to her position as the stock flatlines for the year despite tech hardware rallying. Her timing looks deliberate, buying near the low end of the range while competitors trade at all-time highs.

NCLH director buys $475K near 52-week low as cruise demand cools

Director Jonathan Cohen just bought $475K of Norwegian Cruise Line at $16, a dollar above the 52-week low. The stock has been cut in half from its February peak as the company faces a fraud investigation. Cohen now owns 43.5% more shares than he did yesterday, and this was his call, not a pre-planned trade.

Norwegian CFO buys $451K near 52-week low as cruise stocks lag

Board member Jose Cil dropped $451K into Norwegian Cruise at $16, just above the 52-week low of $15. Discretionary buy, not pre-planned. The stock is down 41% from its peak while the company faces a fraud investigation from Schall Law Firm. Cil now has a third of his holdings purchased at this level.

BSX director buys $251K near 52-week low after 50% drop

Director Habiger bought $251K of BSX at $57, discretionary and not pre-planned. The stock has cratered 48% from its 52-week high of $110 despite the company just spending $1.5B to expand in aortic stenosis. His purchase represents 28% of his total holdings, a meaningful bet at what could be a floor.

Boston Scientific director buys $203K as stock sits near 52-week low

Board member Ludwig just bought $203K of BSX at $57, discretionary and near the 52-week low of $53. The stock has cratered 48% from its $110 peak despite the company just dropping $1.5B to expand in aortic stenosis. Ludwig increased his stake by 12% while the market treats this like a failed trade.

Tractor Supply taps debt markets with new credit facility

Tractor Supply tapped its $1.5B revolving credit facility, drawing down the full amount in one go. The rural retailer's stock is already down 50% from its 52-week high at $32, suggesting this cash raise is about shoring up liquidity rather than funding expansion. With shares near decade lows and credit lines getting maxed out, the company is clearly in defensive mode.

Equity Residential names new officer, amends bylaws, enters material agreement

Equity Residential shuffled its executive suite, bringing in a new CFO while its former finance chief moves to a different role. The REIT also amended its bylaws and disclosed other corporate updates in a kitchen-sink 8-K covering eight different items. EQR stock is flat on the year, trading near the middle of its 52-week range as investors digest the leadership changes.

AvalonBay enters material agreement, makes Reg FD disclosure

AvalonBay signed a material agreement and issued an FD disclosure, suggesting a strategic transaction or financing move that required immediate public notice. The REIT is trading mid-range after a flat year, leaving room for either direction depending on the deal's terms. Watch for details in the exhibits, these dual filings typically mean capital deployment or asset sales that could reshape the portfolio or balance sheet.

Market Context